Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC vs TAC+5FU for Post-Surgical Keloids
NCT04710719Completed
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Feb 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of fluorouracil in keloid (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoint: Keloid Recurrence by visual assessment at 12 months. Started Feb 2021; status: completed.
02
Drugs
fluorouracil
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04710719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04710719.